Research programme: breast cancer therapeutic lentivirus - American Gene Technologies
Latest Information Update: 01 Aug 2016
At a glance
- Originator American Gene Technologies International
- Class Gene therapies
- Mechanism of Action Cell division inhibitors; Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Breast cancer
Most Recent Events
- 01 Aug 2016 Preclinical trials in Breast cancer in USA (Parenteral)